BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24560422)

  • 1. Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.
    Jenkins AJ; Fu D; Azar M; Stoner JA; Kaufman DG; Zhang S; Klein RL; Lopes-Virella MF; Ma JX; Lyons TJ;
    J Diabetes Complications; 2014; 28(3):353-9. PubMed ID: 24560422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.
    Hunt KJ; Jenkins AJ; Fu D; Stevens D; Ma JX; Klein RL; Azar M; Zhang SX; Lopes-Virella MF; Lyons TJ;
    J Diabetes Complications; 2019 Oct; 33(10):107410. PubMed ID: 31434620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.
    Jenkins AJ; Zhang SX; Rowley KG; Karschimkus CS; Nelson CL; Chung JS; O'Neal DN; Januszewski AS; Croft KD; Mori TA; Dragicevic G; Harper CA; Best JD; Lyons TJ; Ma JX
    Diabet Med; 2007 Dec; 24(12):1345-51. PubMed ID: 17971181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome.
    Choi KM; Hwang SY; Hong HC; Yang SJ; Choi HY; Yoo HJ; Lee KW; Nam MS; Park YS; Woo JT; Kim YS; Choi DS; Youn BS; Baik SH
    Diabetes; 2012 Nov; 61(11):2932-6. PubMed ID: 22837306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasma levels of pigment epithelium-derived factor and renal dysfunction in patients with coronary artery disease.
    Arimura T; Miura S; Sugihara M; Iwata A; Yamagishi S; Saku K
    Cardiol J; 2011; 18(5):515-20. PubMed ID: 21947986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Inoue H
    Diabetes Metab Res Rev; 2009 Jan; 25(1):52-6. PubMed ID: 18677713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes.
    Hui E; Yeung CY; Lee PC; Woo YC; Fong CH; Chow WS; Xu A; Lam KS
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2169-77. PubMed ID: 25166721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus.
    Tabur S; Oğuz E; Sabuncu T; Korkmaz H; Çelik H
    Clin Exp Hypertens; 2015; 37(3):177-83. PubMed ID: 25050869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy.
    Ogata N; Matsuoka M; Matsuyama K; Shima C; Tajika A; Nishiyama T; Wada M; Jo N; Higuchi A; Minamino K; Matsunaga H; Takeda T; Matsumura M
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1176-9. PubMed ID: 17213275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy].
    Chen HB; Jia WP; Lu JX; Bao YQ; Li Q; Lu FD; Lu W; Yu HY; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1230-3. PubMed ID: 17686253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating level of pigment epithelium-derived factor is associated with vascular function and structure: A cross-sectional study.
    Kajikawa M; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Kishimoto S; Matsui S; Aibara Y; Hidaka T; Kihara Y; Chayama K; Goto C; Noma K; Nakashima A; Matsui T; Yamagishi SI; Higashi Y
    Int J Cardiol; 2016 Dec; 225():91-95. PubMed ID: 27716557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of pigment epithelium derived factor with von Willebrand factor and plasminogen activator inhibitor 1 in patients with type 2 diabetes.
    Karasek D; Spurna J; Kubickova V; Krystynik O; Cibickova L; Schovanek J; Goldmannova D
    Physiol Res; 2019 Jun; 68(3):409-418. PubMed ID: 30904010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients.
    Tahara N; Nitta Y; Bekki M; Tahara A; Maeda-Ogata S; Sugiyama Y; Honda A; Igata S; Nakamura T; Sun J; Kurata S; Fujimoto K; Abe T; Matsui T; Yamagishi SI; Fukumoto Y
    J Nucl Cardiol; 2020 Aug; 27(4):1352-1364. PubMed ID: 31407236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss.
    Sabater M; Moreno-Navarrete JM; Ortega FJ; Pardo G; Salvador J; Ricart W; Frühbeck G; Fernández-Real JM
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4720-8. PubMed ID: 20631025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of pigment epithelium-derived factor (PEDF) are inversely associated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans.
    Tahara N; Yamagishi SI; Matsui T; Nishino Y; Honda A; Tahara A; Igata S; Fukumoto Y
    Int J Cardiol; 2015 Apr; 184():14-16. PubMed ID: 25705004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis.
    Terawaki H; Yamagishi S; Funakoshi Y; Matsuyama Y; Terada T; Nakayama K; Ogura M; Hosoya T; Ito S; Era S; Nakayama M
    Ther Apher Dial; 2013 Dec; 17(6):625-30. PubMed ID: 24330558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease.
    Wang F; Ma X; Zhou M; Pan X; Ni J; Gao M; Lu Z; Hang J; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Apr; 12():56. PubMed ID: 23547730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients.
    Jenkins A; Zhang SX; Gosmanova A; Aston C; Dashti A; Baker MZ; Lyons T; Ma JX
    Diabetes Res Clin Pract; 2008 Oct; 82(1):e5-7. PubMed ID: 18715664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma pigment epithelium-derived factor in children with type 2 diabetes mellitus is attributable to obesity.
    Tryggestad JB; Wang JJ; Zhang SX; Thompson DM; Short KR
    Pediatr Diabetes; 2015 Dec; 16(8):600-5. PubMed ID: 25293868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of overhydration and serum pigment epithelium-derived factor with CKD progression in diabetic kidney disease: A prospective cohort study.
    Liu AYL; Pek S; Low S; Moh A; Ang K; Tang WE; Lim Z; Subramaniam T; Sum CF; Lim SC
    Diabetes Res Clin Pract; 2021 Apr; 174():108754. PubMed ID: 33741351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.